Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO2007010294) USE OF DELMOPINOL IN THE TREATMENT OF ACNE
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/2007/010294 International Application No.: PCT/GB2006/002770
Publication Date: 25.01.2007 International Filing Date: 24.07.2006
IPC:
A61K 31/5375 (2006.01) ,A61Q 19/00 (2006.01) ,A61P 17/10 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
535
having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
5375
1,4-Oxazines, e.g. morpholine
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
Q
SPECIFIC USE OF COSMETICS OR SIMILAR TOILET PREPARATIONS
19
Preparations for care of the skin
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
P
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
17
Drugs for dermatological disorders
10
Anti-acne agents
Applicants:
SINCLAIR PHARMACEUTICALS LIMITED [GB/GB]; Unit 4, Godalming Business Centre Woolsack Way Godalming Surrey GU7 1XW, GB (AllExceptUS)
LANE, Jonathan, Douglas [GB/GB]; GB (UsOnly)
Inventors:
LANE, Jonathan, Douglas; GB
Agent:
GILL JENNINGS & EVERY LLP; Broadgate House 7 Eldon Street London EC2M 7LH, GB
Priority Data:
0515138.622.07.2005GB
Title (EN) USE OF DELMOPINOL IN THE TREATMENT OF ACNE
(FR) TRAITEMENT DE L'ACNE
Abstract:
(EN) The present invention relates to the use of a morpholino compound having the general formula: (I) wherein R1 is a straight or branched alkyl group containing 8 to 16 carbon atoms at the 2- or 3-position of the morpholino ring, and R2 is a straight or branched alkyl group containing 2 to 10 carbon atoms, substituted with a hydroxy group except in the alpha-position, or pharmaceutically acceptable salts thereof, in the manufacture of a composition for the treatment of acne.
(FR) L'invention concerne l'utilisation d'un composé morpholino de la formule générale, dans laquelle R1 représente un groupe alkyle droit ou ramifié contenant 8 à 10 atomes de carbone à la position 2 ou 3 du cycle morpholino, et R2 représente un groupe alkyle droit ou ramifié contenant 2 à 10 atomes de carbone, substitués avec un groupe hydroxy à l'exception en position alpha, ou des sels pharmaceutiquement acceptables de ceux-ci, dans la fabrication d'une composition permettant de traiter l'acné.
front page image
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
NO20080816NZ564939MXMX/a/2008/000716KR1020080038332EP1933840BRPI0613749-0
BRPI0613749JP2009502769US20080269222CN101227910CA2614846ES2439453
PT1933840KR1020130126746AU2006271396DK1933840ID048.1611IN155/DELNP/2008